Bonnet E - Search Results

1

Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression.

Izopet J, Cazabat M, Pasquier C, Sandres-Sauné K, Bonnet E, Marchou B, Massip P, Puel J. Izopet J, et al. Among authors: bonnet e. Virology. 2002 Oct 25;302(2):393-404. doi: 10.1006/viro.2002.1621. Virology. 2002. PMID: 12441083 Free article.

2

Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations.

Izopet J, Sailler L, Sandres K, Pasquier C, Bonnet E, Aquilina C, Puel J, Massip P, Marchou B. Izopet J, et al. Among authors: bonnet e. J Med Virol. 1999 Feb;57(2):163-8. J Med Virol. 1999. PMID: 9892402 Clinical Trial.

3

Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.

Izopet J, Bicart-See A, Pasquier C, Sandres K, Bonnet E, Marchou B, Puel J, Massip P. Izopet J, et al. Among authors: bonnet e. J Med Virol. 1999 Dec;59(4):507-11. J Med Virol. 1999. PMID: 10534734 Clinical Trial.

4

Lipodystrophia with protease inhibitors in HIV patients.

Massip P, Marchou B, Bonnet E, Cuzin L, Montastruc JL. Massip P, et al. Among authors: bonnet e. Therapie. 1997 Nov-Dec;52(6):615. Therapie. 1997. PMID: 9734120 No abstract available.

5

Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.

Malavaud B, Dinh B, Bonnet E, Izopet J, Payen JL, Marchou B. Malavaud B, et al. Among authors: bonnet e. Antivir Ther. 2000 Mar;5(1):3-5. Antivir Ther. 2000. PMID: 10846585

6

Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen.

Izopet J, Massip P, Souyris C, Sandres K, Puissant B, Obadia M, Pasquier C, Bonnet E, Marchou B, Puel J. Izopet J, et al. Among authors: bonnet e. AIDS. 2000 Oct 20;14(15):2247-55. doi: 10.1097/00002030-200010200-00005. AIDS. 2000. PMID: 11089612

7

Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy.

Bonnet E, Genoux A, Bernard J, Fauvel J, Massip P, Perret B. Bonnet E, et al. Clin Chem Lab Med. 2007;45(7):815-21. doi: 10.1515/CCLM.2007.140. Clin Chem Lab Med. 2007. PMID: 17617020 Review.

8

Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.

Delpierre C, Bonnet E, Marion-Latard F, Aquilina C, Obadia M, Marchou B, Massip P, Perret B, Bernard J. Delpierre C, et al. Among authors: bonnet e. J Clin Densitom. 2007 Oct-Dec;10(4):376-80. doi: 10.1016/j.jocd.2007.07.006. Epub 2007 Sep 20. J Clin Densitom. 2007. PMID: 17888698

9

Association of APOC3 polymorphisms with both dyslipidemia and lipoatrophy in HAART-receiving patients.

Bonnet E, Bernard J, Fauvel J, Massip P, Ruidavets JB, Perret B. Bonnet E, et al. AIDS Res Hum Retroviruses. 2008 Feb;24(2):169-71. doi: 10.1089/aid.2007.0076. AIDS Res Hum Retroviruses. 2008. PMID: 18240956

10

Neurotoxicity of artemisinin: possible counseling and treatment of side effects.

Elias Z, Bonnet E, Marchou B, Massip P. Elias Z, et al. Among authors: bonnet e. Clin Infect Dis. 1999 Jun;28(6):1330-1. doi: 10.1086/517789. Clin Infect Dis. 1999. PMID: 10451183 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters